Mark Dawson

Mark Dawson has a diverse work experience in business development roles within the pharmaceutical industry. Mark has served as the Director of Business Development at Avara Pharmaceutical Services since April 2023. Prior to that, they were the Director of Sales, Drug Product at Curia (formerly AMRI) from November 2021 to April 2023. Mark also worked as the Senior Director of Business Development at BioDuro-Sundia from May 2021 to January 2022 and as the Sr. Director, Business Development at Bora Pharmaceuticals from May 2020 to May 2021. Before that, they held the position of Business Development Executive at Eurofins Alphora, Alphora Research Inc from April 2018 to May 2020 and Account Executive at Catalent Pharma Solutions from August 2015 to April 2018. Mark also served as the Director of Business Development at AAIPharma Services Corp. from February 2013 to July 2015 and as the Business Development Manager at Patheon from May 2007 to February 2013.

Mark Dawson obtained a Bachelor's degree in Chemistry from the University of California, Davis. However, no information is available regarding the specific years of their education or any other educational institutions they may have attended.